About
We are developing state-of-the-art minimally invasive surgical methodologies for treating structural heart diseases like Tricuspid Regurgitation (TR), Mitral Regurgitation (MR). And we We have finished first-in-man study and Early Feasibility Study of Pivot Bridge, a trans-catheter device for treating TR. We are based in Korea and the U.S.A. For more details, please visit our web site and refer the articles.
Technologies
Gmail
Google Apps
Google Cloud Hosting
Nginx
Varnish
Mobile Friendly
Google Tag Manager
Wix
YouTube
AI
Keywords
medical device
catheter
heart disease
heart valve
structural heart disease
mr
tr
hocm
tricuspid regurgitation
ttvi
ttvr
catheter-based therapies
medical equipment and supplies manufacturing
self-centering valve support
device customization
transcatheter tricuspid support
services
self-centering cardiac device
catheter delivery system
flow-guided support system
self-centering support
flow-guided anchoring
flow-guided support
non-penetrating anchors
saline-filled spacer technology
reversible implant
cardiovascular devices
flow stability
reversible cardiac devices
heart valve therapy
Company Information
-
Employees 18
-
Founded 2014
Location
Yangsan, Gyeongsangnam-do, South Korea, 626-810
